Experts hold out hope for Healthpoint's spray-on cell therapy for venous leg ulcers
10:20 EDT 3 Aug 2012 | SCRIP
Healthpoint Biotherapeutics is to start a US Phase III trial of its novel cell-based treatment for venous leg ulcers HP802-247 later this year, with a similar study due to follow shortly after in the EU, based on highly promising Phase II.....
Original Article: Experts hold out hope for Healthpoint's spray-on cell therapy for venous leg ulcers
More From BioPortfolio on "Experts hold out hope for Healthpoint's spray-on cell therapy for venous leg ulcers"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
